WENDY SUSSMAN — Lobbyist Profile | Poliscope

WENDY SUSSMAN

Filings

Clients

Firms

Years active

2022–2026

Associated filing income

—

How to read the money

Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.

Clients represented

Client	Filings	Years
JOHNSON & JOHNSON SERVICES INC	19	2022–2026

Lobbying firms

Firm	Filings	Years
JOHNSON & JOHNSON SERVICES, INC.	19	2022–2026

Bills explicitly cited in this lobbyist’s assigned issues (100)

No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.

H.R. 1492

To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

Original LDA source filings (19)

Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2026 · third_quarter · Q3

Firm income: —Client expense: $2,220,000Open original LDA filing ↗

Assigned issues and filing targets (4 issues)

PHA

Pharmacy

- H.R. 2483, "SUPPORT for Patients and Communities Reauthorization Act of 2025", regarding all provisions.

VET

Veterans

Issues related to: - Veterans Administration and Veterans Health Administration procurement and contracting processes for medical technology - VA Program - military/veterans affairs health workforce and talent workforce

CPT

Source: Senate LDA

H.R. 1492

To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 1492

To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 1539

Medical Device Electronic Labeling Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

Show 96 more cited filings

H.R. 1539

Medical Device Electronic Labeling Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 1539

Medical Device Electronic Labeling Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 2214

DRUG Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 2214

DRUG Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 2214

DRUG Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 2483

SUPPORT for Patients and Communities Reauthorization Act of 2025

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 2483

SUPPORT for Patients and Communities Reauthorization Act of 2025

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 2483

SUPPORT for Patients and Communities Reauthorization Act of 2025

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 2527

Early Detection of Vision Impairments for Children Act of 2025

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 2527

Early Detection of Vision Impairments for Children Act of 2025

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 2527

Early Detection of Vision Impairments for Children Act of 2025

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 3006

To amend title XVIII of the Social Security Act to limit the coinsurance amount for certain services furnished in an ambulatory surgical center.

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 3006

To amend title XVIII of the Social Security Act to limit the coinsurance amount for certain services furnished in an ambulatory surgical center.

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 3006

To amend title XVIII of the Social Security Act to limit the coinsurance amount for certain services furnished in an ambulatory surgical center.

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 3269

ETHIC Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 3269

ETHIC Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 3269

ETHIC Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 3514

Improving Seniors’ Timely Access to Care Act of 2025

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 3514

Improving Seniors’ Timely Access to Care Act of 2025

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 3514

Improving Seniors’ Timely Access to Care Act of 2025

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 3521

Clinical Trial Modernization Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 3521

Clinical Trial Modernization Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 3521

Clinical Trial Modernization Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 3953

SBIR/STTR Website Improvement Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 4282

Contact Lens Prescription Verification Modernization Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 4282

Contact Lens Prescription Verification Modernization Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 4282

Contact Lens Prescription Verification Modernization Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 4299

Protecting Patient Access to Cancer and Complex Therapies Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 4299

Protecting Patient Access to Cancer and Complex Therapies Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 4299

Protecting Patient Access to Cancer and Complex Therapies Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 5256

340B ACCESS Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 5256

340B ACCESS Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 5256

340B ACCESS Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 5343

Ensuring Patient Access to Critical Breakthrough Products Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 5343

Ensuring Patient Access to Critical Breakthrough Products Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 5343

Ensuring Patient Access to Critical Breakthrough Products Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 5509

Safe Step Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 5509

Safe Step Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 5509

Safe Step Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 5526

Biosimilar Red Tape Elimination Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 5526

Biosimilar Red Tape Elimination Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 5526

Biosimilar Red Tape Elimination Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 6197

Health Tech Investment Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 6197

Health Tech Investment Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 6197

Health Tech Investment Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 6549

VA Contracting and Procurement Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 6549

VA Contracting and Procurement Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 6549

VA Contracting and Procurement Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 7391

Community Health Center Drug Pricing Protection Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 7391

Community Health Center Drug Pricing Protection Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 7391

Community Health Center Drug Pricing Protection Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 929

Dr. Lorna Breen Health Care Provider Protection Reauthorization Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 929

Dr. Lorna Breen Health Care Provider Protection Reauthorization Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 929

Dr. Lorna Breen Health Care Provider Protection Reauthorization Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 946

ORPHAN Cures Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 946

ORPHAN Cures Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

H.R. 946

ORPHAN Cures Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

HRES 1301

Supporting the designation of May 29, 2026, as "Mental Health Awareness in Agriculture Day" to raise awareness around mental health in the agricultural industry and workforce and to continue to reduce stigma associated with mental illness.

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

HRES 1301

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

HRES 1301

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

S. 1040

Drug Competition Enhancement Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

S. 1040

Drug Competition Enhancement Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

S. 1040

Drug Competition Enhancement Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

S. 1041

Affordable Prescriptions for Patients Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

S. 1041

Affordable Prescriptions for Patients Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

S. 1041

Affordable Prescriptions for Patients Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

S. 1097

Interagency Patent Coordination and Improvement Act of 2025

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

S. 1097

Interagency Patent Coordination and Improvement Act of 2025

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

S. 1097

Interagency Patent Coordination and Improvement Act of 2025

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

S. 1399

Health Tech Investment Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

S. 1399

Health Tech Investment Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

S. 1399

Health Tech Investment Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

S. 1717

Ensuring Patient Access to Critical Breakthrough Products Act of 2025

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

S. 1717

Ensuring Patient Access to Critical Breakthrough Products Act of 2025

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

S. 1717

Ensuring Patient Access to Critical Breakthrough Products Act of 2025

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

S. 1776

Medicare Beneficiary Co-Pay Fairness Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

S. 1776

Medicare Beneficiary Co-Pay Fairness Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

S. 1776

Medicare Beneficiary Co-Pay Fairness Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

S. 1874

Title VIII Nursing Workforce Reauthorization Act of 2026

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

S. 1954

Biosimilar Red Tape Elimination Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

S. 1954

Biosimilar Red Tape Elimination Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

S. 1954

Biosimilar Red Tape Elimination Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

S. 2276

ETHIC Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

S. 2276

ETHIC Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

S. 2276

ETHIC Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

S. 2658

Medication Affordability and Patent Integrity Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

S. 2658

Medication Affordability and Patent Integrity Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

S. 2658

Medication Affordability and Patent Integrity Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

S. 266

Dr. Lorna Breen Health Care Provider Protection Reauthorization Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

S. 266

Dr. Lorna Breen Health Care Provider Protection Reauthorization Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

S. 266

Dr. Lorna Breen Health Care Provider Protection Reauthorization Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

S. 2903

Safe Step Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

S. 2903

Safe Step Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

S. 2903

Safe Step Act

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

S. 832

EPIC Act of 2025

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

S. 832

EPIC Act of 2025

Client: JOHNSON & JOHNSON SERVICES INC · Firm: JOHNSON & JOHNSON SERVICES, INC.

Open original LDA filing ↗

Cited source text

HCR

Health Issues

- H.R. 1539, Medical Device Electronic Labeling Act, regarding all provisions - H.R. 929/S. 266, the Dr. Lorna Breen Health Care Provider Protection Reauthorization Act, regarding all provisions - H.R. 946 ORPHAN Cures Act, regarding all provisions - S.864, HELP Copays Act, regarding all provisions - H.R. 2214, Delinking Revenue from Unfair Gouging (DRUG) Act, regarding all provisions - H.R. 1492/S. 832, Ensuring Pathways to Innovative Cures (EPIC) Act, regarding all provisions - S. 1954/ H.R. 5526 Biosimilar Red Tape Elimination Act, regarding all provisions - H.R.2527, Early Detection of Vision Impairments for Children Act of 2025, regarding all provisions - PL117-169 The Inflation Reduction Act, regarding all provisions related to drug pricing and implementation - H.R.5343/S. 1717, the Ensuring Patient Access to Critical Breakthrough Products Act of 2025, regarding all provisions - H.R.4282, Contact Lens Prescription Verification Modernization Act, regarding all provisions - H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act, regarding all provisions - S.1399 / H.R. 6197, the Health Tech Investment Act, regarding all provisions - H.R. 3521, the Clinical Trial Modernization Act, regarding all provisions - H.R. 3006 / S.1776, the Medicare Beneficiary Co-Pay Fairness Act, regarding all provisions - H.R. 3514, the Improving Seniors Timely Access to Care Act of 2025, regarding all provisions - H.R. 6549, the VA Contracting and Procurement Act, regarding all provisions - H.R. 5509 / S. 2903, Safe Step Act, regarding all provisions - H.R. 5256, 340B ACCESS Act, regarding all provisions - H.R. 7391, Community Health Center Drug Pricing Protection Act, regarding all provisions - H.R. 3953 / S. 1874 Title VIII Nursing Workforce Reauthorization Act, regarding all provisions Issues related to - direct to consumer advertising - clinical trial modernization - biosimilars - cardiovascular health - 340B and 340B Rebate Pilot - Heart Recovery Awareness Day & H.Res. 1301, designating February 20th Heart Recovery Awareness Day - MFN - Foreign Reference Pricing - CMS Outpatient Prospective Payment System rule - peripheral artery disease (PAD) - PBM and Insurer Reforms

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2026 · second_quarter · Q2

Firm income: —Client expense: $1,440,000Open original LDA filing ↗

Assigned issues and filing targets (4 issues)

PHA

Pharmacy

- H.R. 2483, "SUPPORT for Patients and Communities Reauthorization Act of 2025", regarding all provisions.

HCR

Health Issues

- H.R. 1539, Medical Device Electronic Labeling Act, regarding all provisions - H.R. 929/S. 266, the Dr. Lorna Breen Health Care Provider Protection Reauthorization Act, regarding all provisions - H.R. 946 ORPHAN Cures Act, regarding all provisions - S.864, HELP Copays Act, regarding all provisions - H.R. 2214, Delinking Revenue from Unfair Gouging (DRUG) Act, regarding all provisions - H.R. 1492/S. 832, Ensuring Pathways to Innovative Cures (EPIC) Act - S. 1954/ H.R. 5526 Biosimilar Red Tape Elimination Act, regarding all provisions - H.R.2527, Early Detection of Vision Impairments for Children Act of 2025, regarding all provisions - PL117-169 The Inflation Reduction Act, regarding all provisions related to drug pricing and implementation - H.R.5343/S. 1717, the Ensuring Patient Access to Critical Breakthrough Products Act of 2025, regarding all provisions - H.R.4282, Contact Lens Prescription Verification Modernization Act, regarding all provisions - H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act, regarding all provisions - S.1399 / H.R. 6197, the Health Tech Investment Act, regarding all provisions - H.R. 3521, the Clinical Trial Modernization Act, regarding all provisions - H.R. 3006 / S.1776, the Medicare Beneficiary Co-Pay Fairness Act, regarding all provisions - H.R. 3514, the Improving Seniors Timely Access to Care Act of 2025, regarding all provisions - H.R. 6549, the VA Contracting and Procurement Act, regarding all provisions - H.R. 5509 / S. 2903, Safe Step Act, regarding all provisions - H.R. 5256, 340B ACCESS Act, regarding all provisions - H.R. 7391, Community Health Center Drug Pricing Protection Act, regarding all provisions Issues related to - direct to consumer advertising - clinical trial modernization - biosimilars - cardiovascular health - 340B and 340B Rebate Pilot - Heart Recovery Awareness Day & H.Res. 1301, designating February 20th Heart Recovery Awareness Day - obesity treatments - MFN - Foreign Reference Pricing - CMS Outpatient Prospective Payment System rule - peripheral artery disease (PAD) - PBM and Insurer Reforms

VET

Veterans

CPT

- S. 1040, Drug Competition Enhancement Act, regarding all provisions - S. 1041, Affordable Prescriptions for Patients Act of 2025, regarding all provisions - S. 1097, Interagency Patent Coordination and Improvement Act of 2025, regarding all provisions - H.R. 3269/S. 2276, Eliminating Thickets to Increase Competition (ETHIC) Act, regarding all provisions - S.2658, Medication Affordability and Patent Integrity Act Issues related to: - intellectual property, including amending the Federal Trade Commission Act to prohibit product hopping - patent thickets - patent fees

Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of, U.S. Trade Representative (USTR), Veterans Affairs, Dept of (VA), White House Office

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2026 · first_quarter · Q1

Firm income: —Client expense: $3,510,000Open original LDA filing ↗

Assigned issues and filing targets (4 issues)

VET

Veterans

HCR

Health Issues

- H.R. 1539, Medical Device Electronic Labeling Act, regarding all provisions - H.R. 929/S. 266, the Dr. Lorna Breen Health Care Provider Protection Reauthorization Act, regarding all provisions - H.R. 946 ORPHAN Cures Act, regarding all provisions - S.864, HELP Copays Act, regarding all provisions - H.R. 2214, Delinking Revenue from Unfair Gouging (DRUG) Act, regarding all provisions - H.R. 1492/S. 832, Ensuring Pathways to Innovative Cures (EPIC) Act - S. 1954/ H.R. 5526 Biosimilar Red Tape Elimination Act, regarding all provisions - H.R.2527, Early Detection of Vision Impairments for Children Act of 2025, regarding all provisions - PL117-169 The Inflation Reduction Act, regarding all provisions related to drug pricing and implementation - H.R.5343/S. 1717, the Ensuring Patient Access to Critical Breakthrough Products Act of 2025, regarding all provisions - H.R.4282, Contact Lens Prescription Verification Modernization Act, regarding all provisions - H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act, regarding all provisions - S.1399 / H.R. 6197, the Health Tech Investment Act, regarding all provisions - H.R. 3521, the Clinical Trial Modernization Act, regarding all provisions - H.R. 3006 / S.1776, the Medicare Beneficiary Co-Pay Fairness Act, regarding all provisions - H.R. 3514, the Improving Seniors Timely Access to Care Act of 2025, regarding all provisions - H.R. 6549, the VA Contracting and Procurement Act, regarding all provisions - H.R. 5509 / S. 2903, Safe Step Act, regarding all provisions - H.R. 5256, 340B ACCESS Act, regarding all provisions - H.R. 7391, Community Health Center Drug Pricing Protection Act, regarding all provisions Issues related to - direct to consumer advertising - clinical trial modernization - biosimilars - cardiovascular health - 340B and 340B Rebate Pilot - Heart Recovery Awareness Day & H.Res. 1301, designating February 20th Heart Recovery Awareness Day - obesity treatments - MFN - Foreign Reference Pricing - CMS Outpatient Prospective Payment System rule - peripheral artery disease (PAD) - PBM and Insurer Reforms

CPT

PHA

Pharmacy

- H.R. 2483, "SUPPORT for Patients and Communities Reauthorization Act of 2025", regarding all provisions.

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2025 · fourth_quarter · Q4

Firm income: —Client expense: $1,510,000Open original LDA filing ↗

Assigned issues and filing targets (4 issues)

HCR

Health Issues

CPT

PHA

Pharmacy

- Issues related to the SUPPORT Act

VET

Veterans

Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of, U.S. Trade Representative (USTR), Veterans Affairs, Dept of (VA), White House Office

Show 15 more original filings

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2025 · third_quarter · Q3

Firm income: —Client expense: $2,480,000Open original LDA filing ↗

Assigned issues and filing targets (3 issues)

VET

Veterans

Issues related to: - Veterans Administration and Veterans Health Administration procurement and contracting processes for medical technology - VA Program

HCR

Health Issues

CPT

- S. 1040, Drug Competition Enhancement Act, regarding all provisions - S. 1041, Affordable Prescriptions for Patients Act of 2025, regarding all provisions - S. 1097, Interagency Patent Coordination and Improvement Act of 2025, regarding all provisions - H.R. 3269/S. 2276, Eliminating Thickets to Increase Competition (ETHIC) Act, regarding all provisions - S.2658, Medication Affordability and Patent Integrity Act Issues related to: - intellectual property, including S. 1040, a bill to amend the Federal Trade Commission Act to prohibit product hopping - patent thickets - patent fees

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2025 · second_quarter · Q2

Firm income: —Client expense: $1,030,000Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

HCR

Health Issues

- H.R. 1539, Medical Device Electronic Labeling Act, regarding all provisions - S. 266, the Dr. Lorna Breen Health Care Provider Protection Reauthorization Act, regarding all provisions - H.R. 946 ORPHAN Cures Act, regarding all provisions - S.864, HELP Copays Act, regarding all provisions - H.R. 2214, Delinking Revenue from Unfair Gouging (DRUG) Act, regarding all provisions - H.R. 1492/S. 832, Ensuring Pathways to Innovative Cures (EPIC) Act - S. 1954, Biosimilar Red Tape Elimination Act, regarding all provisions - H.R.2527, Early Detection of Vision Impairments for Children Act of 2025, regarding all provisions - PL117-169 The Inflation Reduction Act, regarding all provisions related to drug pricing and implementation Issues related to - direct to consumer advertising - clinical trial modernization - biosimilars - cardiovascular health - 340B - Heart Recovery Awareness Day & H.Res. 1301, designating February 20th Heart Recovery Awareness Day - obesity treatments

CPT

- S. 1040, Drug Competition Enhancement Act, regarding all provisions - S. 1041, Affordable Prescriptions for Patients Act of 2025, regarding all provisions - S. 1097, Interagency Patent Coordination and Improvement Act of 2025, regarding all provisions Issues related to - intellectual property, including S. 1040, a bill to amend the Federal Trade Commission Act to prohibit product hopping - Medication Affordability and Patent Integrity Act - patent thickets

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2025 · first_quarter · Q1

Firm income: —Client expense: $3,340,000Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

HCR

Health Issues

- H.R. 1539, Medical Device Electronic Labeling Act, regarding all provisions - H.R. XXXX/ S. 266, the Dr. Lorna Breen Health Care Provider Protection Reauthorization Act, regarding all provisions - H.R. 946 ORPHAN Cures Act, regarding all provisions - S.864, H.R. XXX HELP Copays Act, regarding all provisions - H.R. 2214/ S. XXXX Delinking Revenue from Unfair Gouging (DRUG) Act, regarding all provisions - H.R. 1492/S. 832, Ensuring Pathways to Innovative Cures (EPIC) Act - PL117-169 The Inflation Reduction Act, regarding all provisions related to drug pricing and implementation Issues related to - direct to consumer advertising - clinical trial modernization - biosimilars - cardiovascular health - 340B - Heart Recovery Awareness Day & H.Res. 1301, designating February 20th Heart Recovery Awareness Day

CPT

- S. 1040, Drug Competition Enhancement Act, regarding all provisions - S. 1041, Affordable Prescriptions for Patients Act of 2025, regarding all provisions - S. 1097, Interagency Patent Coordination and Improvement Act of 2025, regarding all provisions Issues related to - intellectual property, including S. 1040, a bill to amend the Federal Trade Commission Act to prohibit product hopping - Medication Affordability and Patent Integrity Act - patent thickets

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2024 · fourth_quarter · Q4

Firm income: —Client expense: $1,520,000Open original LDA filing ↗

Assigned issues and filing targets (3 issues)

HCR

Health Issues

- S 1375/HR 830, "HELP Copays Act", regarding all provisions. - PL 117-169, "The Inflation Reduction Act", regarding provisions impacting drug pricing and implementation. - PL 113-5 "Pandemic All Hazards Preparedness Reauthorization", regarding all provisions. - S 1355/HR 2940, "PASTEUR Act", regarding all provisions. - HR 3723, "Medical Device Electronic Labeling Act", regarding all provisions. - HR 2748, "Contact Lens Prescription Verification Modernization Act", regarding all provisions. - HR 4261, "Amputation Reduction and Compassion Act", regarding all provisions. - S 3131/HR 5539, "ORPHAN Cures Act", regarding all provisions. - HR 5372, "Expanding Access to Seniors Access to Lower Cost Medicines Act of 2023", regarding all provisions. - S 2305, "The Biosimilar Red Tape Elimination Act", regarding all provisions. - HR 1352, "Increasing Access to Biosimilars Act of 2023", regarding all provisions. - HR 7174, "Ensuring Pathways to Innovative Cures (EPIC) Act", regarding all provisions - HR 8574, the "340B Affording Care for Communities and Ensuring a Strong Safety-Net (ACCESS) Act", regarding all provisions - HR 7384, "Creating Hope Reauthorization Act", regarding all provisions - HR 7153/ S 3679 the "Dr. Lorna Breen Health Care Provider Protection Reauthorization Act", regarding all provisions Issues related to: - Obesity - Biosimilars - Health equity and diversity in clinical trials - Myopia - Ambulatory surgical services - Access to sterilization capacity for medical technologies - Peripheral artery disease - Cardiovascular health - Stroke care - FDA medical device shortage reporting requirements - Alternative funding programs - PBM practices - Health care workforce wellbeing - Medicaid Drug Rebate Program - the SUSTAIN 340B Act

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2024 · third_quarter · Q3

Firm income: —Client expense: $2,340,000Open original LDA filing ↗

Assigned issues and filing targets (4 issues)

PHA

Pharmacy

- HR 4490, "To amend the Controlled Substances Act to authorize pharmacies to deliver certain controlled substances to an administering practitioner in lieu of delivering such substances to the to the ultimate user, and for other purposes", regarding all provisions. - Issues related to drug shortages.

HCR

Health Issues

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2024 · second_quarter · Q2

Firm income: —Client expense: $1,120,000Open original LDA filing ↗

Assigned issues and filing targets (4 issues)

TRD

Trade (domestic/foreign)

Issues related to: - Medical supply chains - TRIPS Waiver

MMM

Medicare/Medicaid

Issues related to the Medicaid Drug Rebate Program.

PHA

Pharmacy

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2024 · first_quarter · Q1

Firm income: —Client expense: $2,730,000Open original LDA filing ↗

Assigned issues and filing targets (4 issues)

TRD

Trade (domestic/foreign)

Issues related to: - Medical supply chains - TRIPS Waiver

MMM

Medicare/Medicaid

Issues related to the Medicaid Drug Rebate Program.

PHA

Pharmacy

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2023 · fourth_quarter · Q4

Firm income: —Client expense: $1,160,000Open original LDA filing ↗

Assigned issues and filing targets (3 issues)

PHA

Pharmacy

TRD

Trade (domestic/foreign)

Issues related to: - Medical supply chains - TRIPS Waiver

HCR

Health Issues

- S 1375/HR 830, "HELP Copays Act", regarding all provisions - PL 117-169, "The Inflation Reduction Act", regarding provisions impacting drug pricing and implementation - PL 113-5 "Pandemic All Hazards Preparedness Reauthorization", regarding all provisions - S 1355/HR 2940, "PASTEUR Act", regarding all provisions - HR 3723, "Medical Device Electronic Labeling Act", regarding all provisions - HR 2748, "Contact Lens Prescription Verification Modernization Act", regarding all provisions - HR 4261, "Amputation Reduction and Compassion Act", regarding all provisions - S 3131/HR 5539, "ORPHAN Cures Act", regarding all provisions - HR 5372, "Expanding Access to Seniors Access to Lower Cost Medicines Act of 2023", regarding all provisions - S 2305, "The Biosimilar Red Tape Elimination Act", regarding all provisions - HR 1352, "Increasing Access to Biosimilars Act of 2023", regarding all provisions Issues related to: - Obesity - Biosimilars - Health equity and diversity in clinical trials - Myopia - Ambulatory surgical services - Access to sterilization capacity for medical technologies - Peripheral artery disease - Cardiovascular health - Stroke care - FDA medical device shortage reporting requirements - Alternative funding programs - 340B - PBM practices - Health care workforce wellbeing - Medicaid Drug Rebate Program

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2023 · third_quarter · Q3

Firm income: —Client expense: $2,350,000Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

PHA

Pharmacy

HCR

Health Issues

- S 1375/HR 830, "HELP Copays Act", regarding all provisions - PL 117-169, "The Inflation Reduction Act", regarding provisions impacting drug pricing and implementation - PL 113-5 "Pandemic All Hazards Preparedness Reauthorization", regarding all provisions - S 1355/HR 2940, "PASTEUR Act", regarding all provisions - HR 3723, "Medical Device Electronic Labeling Act", regarding all provisions - HR 2748, "Contact Lens Prescription Verification Modernization Act", regarding all provisions - HR 4261, "Amputation Reduction and Compassion Act", regarding all provisions Issues related to: - obesity - biosimilars - health equity and diversity in clinical trials - myopia - ambulatory surgical services - access to sterilization capacity for medical technologies - FDA approval pathways for medical technologies - peripheral artery disease - cardiovascular health - stroke care - FDA medical device shortage reporting requirements - alternative funding programs - 340B - PBM practices - health care workforce wellbeing

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2023 · second_quarter · Q2

Firm income: —Client expense: $850,000Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

- S 1375/HR 830, "HELP Copays Act", regarding all provisions - PL 117-169, "The Inflation Reduction Act", regarding provisions impacting drug pricing and implementation - PL 113-5 "Pandemic All Hazards Preparedness Reauthorization", regarding all provisions - S 1355/HR 2940, "PASTEUR Act", regarding all provisions - HR 3723, "Medical Device Electronic Labeling Act", regarding all provisions - HR 2748, "Contact Lens Prescription Verification Modernization Act", regarding all provisions - HR 4261, "Amputation Reduction and Compassion Act", regarding all provisions Issues related to: - obesity - biosimilars - health equity and diversity in clinical trials - myopia - ambulatory surgical services - access to sterilization capacity for medical technologies - FDA approval pathways for medical technologies - peripheral artery disease - cardiovascular health - stroke care - FDA medical device shortage reporting requirements - alternative funding programs - 340B - PBM practices - health care workforce wellbeing

Filing targets: Centers For Medicare and Medicaid Services (CMS), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2023 · first_quarter · Q1

Firm income: —Client expense: $2,490,000Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

- HR 830, "HELP Copays Act", regarding all provisions - S 652, "Safe Step Act", regarding all provisions - PL 117-169, "The Inflation Reduction Act", regarding provisions impacting drug pricing and implementation - PL 113-5 "Pandemic All Hazards Preparedness Reauthorization", regarding all provisions - PL 115-271, "SUPPORT Act", regarding Section 3204 - PASTEUR Act (2021), regarding all provisions Issues related to: - obesity - biosimilars - health equity and diversity in clinical trials - myopia - ambulatory surgical services - access to sterilization capacity for medical technologies - FDA approval pathways for medical technologies - peripheral artery disease - cardiovascular health - stroke care - FDA medical device shortage reporting requirements - alternative funding programs - 340B - PBM practices - health care workforce wellbeing

Filing targets: Centers For Medicare and Medicaid Services (CMS), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2022 · fourth_quarter · Q4

Firm income: —Client expense: $2,270,000Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

TAX

Taxation/Internal Revenue Code

- HR 5214, "To amend the Internal Revenue Code of 1986 to permit expenditures from health savings accounts, flexible spending arrangements, and health reimbursement arrangements for dietary supplements.", regarding expenditures from HSAs, FSAs, and health reimbursement arrangements for dietary supplements - Issues related to Health Spending Accounts & Flexible Spending Accounts - Issues related to corporate tax provisions of reconciliation bill - U.S. Treasury policy and negotiating positions related to tax at the Organisation for Economic Co-operation and Development ("OECD") - Issues related to US Treasury implementation of new corporate alternative minimum tax - Issues related to WTO TRIPS agreement

HCR

Health Issues

- HR 1978/S 912, "Protecting Seniors Through Immunization Act", regarding all provisions - HR 6007, "To amend title XVIII of the Social Security Act to provide for the expansion of coverage of vaccines under part B of the Medicare program, and for other purposes", regarding all provisions - H.Res. 446, Expressing support for the goals and ideals of National Stroke Awareness Month, regarding all provisions - S 610/HR 1667, "The Dr. Lorna Breen Health Care Provider Protection Act", regarding all provisions - HR 3, "Elijah E. Cummings Lower Drug Costs Now Act", regarding all provisions - S 1784/HR 3353, Contact Lens Prescription Verification Modernization Act, regarding all provisions - HR 5030/S 2706, "The Diversifying Investigations Via Equitable Research Studies for Everyone (DIVERSE) Trials Act, regarding all provisions - S 3394, "Emergency Use Transparency Act", regarding all provisions - HR 3990/S 2047, "No PFAS in Cosmetics Act", regarding all provisions - HR 8299/S 4386, "To allow for devices with a predetermined change control plan to be marketed without submitting a supplemental application or premarket notification if the changes to such devices are consistent with such plan.", regarding all provisions - HR 7667/S 4348, "Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act", regarding provisions on accelerated approval and diversity in clinical studies - HR 5801, "HELP Copays Act", regarding all provisions - HR 3173/S 3018 - "Improving Seniors Timely Access to Care Act of 2021", regarding all provisions - S 3799 - "PREVENT Pandemics Act", regarding all provisions - HR 3932/S 2076 - "PASTEUR Act of 2021", regarding all provisions - HR 5376 - "Inflation Reduction Act", regarding provisions on drug pricing and provisions related to revenue - HR 7559 - Prescription Information Modernization Act of 2022, regarding all provisions - HR 2617 - "Consolidated Appropriations Act, 2023", regarding provisions related to pharmaceuticals, medical devices, mental health, and tax - Issues related to Dengue - Issues related to prescription drug pricing - Issues related to health care pricing transparency - Issues related to maternal health - Issues related to frontline health workers - Issues related to over the counter products - Issues related to the regulation of cosmetic products - Issues related to the regulation of dietary supplements - Issues related to stroke care - Issues related to counterfeit health care goods - Issues related to 340B drug pricing program - Issues related to antimicrobial resistance - Issues related to the COVID-19 vaccine development, including diversity in clinical trials - Issues related to Medicare Part D's 6 protected classes - Issues related to global public health and ending tuberculosis - Issues pertaining to health equity and social determinants of health - Issues related to FDA medical device shortage reporting requirements, including implementation of CARES Act requirements - Issues related to lung cancer screening - Issues related to clinical research diversity - Issues related to international harmonization of medical device regulation

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2022 · third_quarter · Q3

Firm income: —Client expense: $2,170,000Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

- HR 1978/S 912, "Protecting Seniors Through Immunization Act", regarding all provisions - HR 6007, "To amend title XVIII of the Social Security Act to provide for the expansion of coverage of vaccines under part B of the Medicare program, and for other purposes", regarding all provisions - H.Res. 446, Expressing support for the goals and ideals of National Stroke Awareness Month, regarding all provisions - S 610/HR 1667, "The Dr. Lorna Breen Health Care Provider Protection Act", regarding all provisions - HR 3, "Elijah E. Cummings Lower Drug Costs Now Act", regarding all provisions - S 1784/HR 3353, Contact Lens Prescription Verification Modernization Act, regarding all provisions - HR 5030/S 2706, "The Diversifying Investigations Via Equitable Research Studies for Everyone (DIVERSE) Trials Act, regarding all provisions - S 3394, "Emergency Use Transparency Act", regarding all provisions - HR 5376, "Build Back Better Act", regarding provisions on drug pricing and provisions related to revenue - HR 3990/S 2047, "No PFAS in Cosmetics Act", regarding all provisions - HR 8299/S 4386, FDA review of certain changes to software in medical devices or predetermined change control plans - HR 7667/S 4348, "Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act", regarding provisions on accelerated approval and diversity in clinical studies - HR 5801, "HELP Copays Act", regarding all provisions - HR 3173/S 3018 - "Improving Seniors Timely Access to Care Act of 2021" - S 3799 - "PREVENT Pandemics Preparedness Act" - HR 3932/S 2079 - "PASTEUR Act of 2021" - HR 5376 - "Inflation Reduction Act", regarding provisions on prescription drugs - Issues related to Dengue - Issues related to prescription drug pricing - Issues related to health care pricing transparency - Issues related to maternal health - Issues related to frontline health workers - Issues related to over the counter products - Issues related to the regulation of cosmetic products - Issues related to the regulation of dietary supplements - Issues related to stroke care - Issues related to counterfeit health care goods - Issues related to 340B drug pricing program - Issues related to antimicrobial resistance - Issues related to the COVID-19 vaccine development, including diversity in clinical trials - Issues related to Medicare Part D's 6 protected classes - Issues related to global public health and ending tuberculosis - Issues pertaining to health equity and social determinants of health - Issues related to FDA medical device shortage reporting requirements, including implementation of CARES Act requirements - Issues related to lung cancer screening - Issues related to clinical research diversity - Issues related to international harmonization of medical device regulation

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2022 · second_quarter · Q2

Firm income: —Client expense: $1,050,000Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

- HR 1978/S 912, "Protecting Seniors Through Immunization Act", regarding all provisions - HR 6007, "To amend title XVIII of the Social Security Act to provide for the expansion of coverage of vaccines under part B of the Medicare program, and for other purposes", regarding all provisions - H.Res. 446, Expressing support for the goals and ideals of National Stroke Awareness Month, regarding all provisions - S 610/HR 1667, "The Dr. Lorna Breen Health Care Provider Protection Act", regarding all provisions - HR 3, "Elijah E. Cummings Lower Drug Costs Now Act", regarding all provisions - S 1784/HR 3353, Contact Lens Prescription Verification Modernization Act, regarding all provisions - HR 5030/S 2706, "The Diversifying Investigations Via Equitable Research Studies for Everyone (DIVERSE) Trials Act, regarding all provisions - S 3394, "Emergency Use Transparency Act", regarding all provisions - HR 5376, "Build Back Better Act", regarding provisions on drug pricing and provisions related to revenue - HR 3990/S 2047, "No PFAS in Cosmetics Act", regarding all provisions - HR 8299/S 4386, FDA review of certain changes to software in medical devices or predetermined change control plans - HR 7667/S 4348, "Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act", regarding provisions on accelerated approval and diversity in clinical studies - HR 5801, "HELP Copays Act", regarding all provisions - Issues related to prescription drug pricing - Issues related to health care pricing transparency - Issues related to maternal health - Issues related to frontline health workers - Issues related to over the counter products - Issues related to the regulation of cosmetic products - Issues related to the regulation of dietary supplements - Issues related to stroke care - Issues related to counterfeit health care goods - Issues related to 340B drug pricing program - Issues related to antimicrobial resistance - Issues related to the COVID-19 vaccine development, including diversity in clinical trials - Issues related to Medicare Part D's 6 protected classes - Issues related to global public health and ending tuberculosis - Issues pertaining to health equity and social determinants of health - Issues related to FDA medical device shortage reporting requirements, including implementation of CARES Act requirements - Issues related to lung cancer screening - Issues related to clinical research diversity - Issues related to international harmonization of medical device regulation

JOHNSON & JOHNSON SERVICES INC via JOHNSON & JOHNSON SERVICES, INC.

2022 · first_quarter · Q1

Firm income: —Client expense: $2,320,000Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

- HR 1978/S 912, "Protecting Seniors Through Immunization Act", regarding all provisions - HR 6007, legislation to expand access to adult vaccines under Medicare Part B, regarding all provisions - H.Res. 446, Expressing support for the goals and ideals of National Stroke Awareness Month - S 610/HR 1667, "The Dr. Lorna Breen Health Care Provider Protection Act" - HR 3, "Elijah E. Cummings Lower Drug Costs Now Act", regarding all provisions - S 1784/HR 3353, the Contact Lens Prescription Verification Modernization Act, regarding all provisions - HR 5030/S 2706, "The Diversifying Investigations Via Equitable Research Studies for Everyone (DIVERSE) Trials Act, regarding all provisions - S 3394, "The Emergency Use Transparency Act", regarding all provisions - HR 5376, "Build Back Better Act", regarding provisions on drug pricing and provisions related to revenue - HR 3990/S 2047, No PFAS in Cosmetics Act - HR 2467, PFAS Action Act of 2021 - Issues related to prescription drug pricing - Issues related to health care pricing transparency - Issues related to maternal health - Issues related to frontline health workers - Issues related to over the counter products - Issues related to the regulation of cosmetic products - Issues related to the regulation of dietary supplements - Issues related to stroke care - Issues related to counterfeit health care goods - Issues related to 340B drug pricing program - Issues related to antimicrobial resistance - Issues related to the COVID-19 vaccine development, including diversity in clinical trials - Issues related to Medicare Part D's 6 protected classes - Issues related to global public health and ending tuberculosis - Issues pertaining to health equity and social determinants of health - Issues related to FDA medical device shortage reporting requirements, including implementation of CARES Act requirements - Issues related to lung cancer screening - Issues related to clinical research diversity - Issues related to international harmonization of medical device regulation - Issues related to FDA review of certain changes to software in medical devices or predetermined change control plans - Issues related to HR ___, "Medical Device User Fee Amendments of 2022"